| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
|
Molina, Ana M.
|
|
2013
|
73 |
1 |
p. 181-189
|
artikel
|
| 2 |
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)
|
Hattori, Yoshihiro
|
|
2013
|
73 |
1 |
p. 17-23
|
artikel
|
| 3 |
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAFV600E mutation-positive metastatic melanoma
|
Grippo, J. F.
|
|
2013
|
73 |
1 |
p. 103-111
|
artikel
|
| 4 |
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
|
Kim, Young Saing
|
|
2013
|
73 |
1 |
p. 163-169
|
artikel
|
| 5 |
Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production
|
Gong, Lei
|
|
2013
|
73 |
1 |
p. 69-77
|
artikel
|
| 6 |
Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers
|
Tawbi, Hussein
|
|
2013
|
73 |
1 |
p. 207-211
|
artikel
|
| 7 |
Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer
|
Jakobsen, Jan Nyrop
|
|
2013
|
73 |
1 |
p. 131-137
|
artikel
|
| 8 |
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma
|
Harmon, Charles S.
|
|
2013
|
73 |
1 |
p. 151-161
|
artikel
|
| 9 |
Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer
|
Yi, Seung Woo
|
|
2013
|
73 |
1 |
p. 191-198
|
artikel
|
| 10 |
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
|
Kang, Yoon-Koo
|
|
2013
|
73 |
1 |
p. 139-149
|
artikel
|
| 11 |
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
|
Owonikoko, Taofeek K.
|
|
2013
|
73 |
1 |
p. 171-180
|
artikel
|
| 12 |
Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma
|
Thomas, Sheeba K.
|
|
2013
|
73 |
1 |
p. 35-42
|
artikel
|
| 13 |
Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients
|
Jakobsen, Jan Nyrop
|
|
2013
|
73 |
1 |
p. 43-51
|
artikel
|
| 14 |
Mechanisms of action of tasquinimod on the tumour microenvironment
|
Raymond, E.
|
|
2013
|
73 |
1 |
p. 1-8
|
artikel
|
| 15 |
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
|
Wit, D. de
|
|
2013
|
73 |
1 |
p. 87-96
|
artikel
|
| 16 |
Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer
|
Cho, Eun Kyung
|
|
2013
|
73 |
1 |
p. 9-16
|
artikel
|
| 17 |
Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study
|
Floquet, Anne
|
|
2013
|
73 |
1 |
p. 61-68
|
artikel
|
| 18 |
Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma
|
Ando, Hitoshi
|
|
2013
|
73 |
1 |
p. 53-60
|
artikel
|
| 19 |
Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer
|
Yamaue, Hiroki
|
|
2013
|
73 |
1 |
p. 97-102
|
artikel
|
| 20 |
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
|
Hong, Jung Yong
|
|
2013
|
73 |
1 |
p. 125-130
|
artikel
|
| 21 |
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors
|
Chiu, Yi-Lin
|
|
2013
|
73 |
1 |
p. 213-217
|
artikel
|
| 22 |
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
|
Joerger, M.
|
|
2013
|
73 |
1 |
p. 113-124
|
artikel
|
| 23 |
Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies
|
Xu, Wei-qun
|
|
2013
|
73 |
1 |
p. 79-86
|
artikel
|
| 24 |
The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma
|
Yang, Chih-Jen
|
|
2013
|
73 |
1 |
p. 199-205
|
artikel
|
| 25 |
Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice
|
Park, Hue Jung
|
|
2013
|
73 |
1 |
p. 25-34
|
artikel
|
Tijdschrift beschrijving